Category Archives: Reasearch

28Oct/25

FAT1 Imaging Revolutionizes Essential Tremor Treatment

Reasearch, , , , , , , ,

The study concerns a new imaging technique called FAT1, developed by consultant neurosurgeon Mr. Harith Akram, which is designed to improve the accuracy and outcomes of MR-guided focused ultrasound (MRgFUS) treatment for patients suffering from essential tremor. This technique, which fuses multiple MRI scan types, aims to overcome the difficulty of visualising the small target area in the brain (the Vim nucleus) during the non-invasive procedure. Continue reading

23Jan/25

AI-Assisted Nursing: A New Research Project

Reasearch, , , , , , ,

Jan. 23, 2025 /Mpelembe Media/ —   A Finnish research project, part of the European ITEA PROFIT initiative, explores using artificial intelligence to alleviate the workload of nurses. The project aims to develop AI tools for tasks like patient registration and information review, freeing up nurses for direct patient care. Continue reading →

06Jan/25

AI-powered tool aids in the early detection of melanoma

Reasearch, , , , , , , , , , , , ,

Jan. 6, 2025 /Mpelembe Media/ — , a medical technology company, is partnering with the Mayo Clinic to pilot its Nevisense device in the US. Nevisense, an FDA-approved AI-powered tool, aids in the early detection of melanoma, the deadliest form of skin cancer. Continue reading →

03Jan/25

Redefining Cancer Treatment

Reasearch, , , , , , , , , , , , , , , , , , , , , , , , , ,

Jan. 3, 2025 /Mpelembe Media/ —  Oncolytics Biotech Inc.’s progress in developing cutting-edge immunotherapies for cancer treatment is the article’s main subject. The piece highlights several key advancements, including clinical trial results and collaborations with other companies. Financial information regarding Oncolytics is included, along with a disclaimer about the nature of the publication. Continue reading →

26Dec/24

Zentiva hosted the “European Health Check”:

Reasearch

A live survey conducted during the “European Health Check” revealed that 77% of participants do not believe the current systemic framework applied to the generics industry is sustainable or effectively ensures the availability and accessibility of medicines for patients across the EU. This eye-opening result underscores the critical need for systemic reforms to support the generics industry, which is fundamental to delivering affordable and accessible healthcare in Europe. Continue reading

22Sep/24

Researchers Find Facemask Impacts are Leading Source of Higher Severity Impacts in Professional American Football

Reasearch, , , , , ,

Nearly one third of concussions in professional American football are due to impacts from the facemask, a part of the helmet that has remained mostly unchanged in the last decade. In a new study presented at the International Research Council on Biomechanics of Injury conference today, researchers used data collected from instrumented mouthpieces worn by players in the National Football League (NFL) that measured head motion and found that facemasks are the most frequent location of impact on a player’s helmet in a subset of high severity impacts. The study findings suggest that facemask enhancements could help protect players and minimize injury risk. Continue reading

22Sep/24

Experts ensure that early detection and proper prevention are key to tackling the future challenges of cancer

Reasearch, , , , ,

MEDSIR, a leading company dedicated to advancing independent clinical research in oncology on an international level and part of Oncoclínicas & Co, the largest oncology treatment group in Latin America with significant strength in the clinical and outpatient setting, showcased its groundbreaking research at this year’s European Society for Medical Oncology (ESMO) Congress held in Barcelona. The company presented 12 new studies that address various types of cancer, marking a significant scientific milestone for MEDSIR. Continue reading

22Sep/24

Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players

Reasearch, , , , , ,

In the oncology world, there’s been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However, there’s still a lot of work to do in the war on cancer, with the 2024 World Cancer Congress in Geneva highlighting several issues, such as artificial intelligence (AI), conflict zones and crisis care taking center stage at the gathering. Continue reading